India
The at $218m round saw participation from PB Fintech and others.
1
The LP View: GPs need to rethink strategy as days of super returns are over in China
2
VIG Partners delays fifth fundraise amid market disruptions, eyes year-end close
3
AllianzGI to ride energy transition, data centre growth in Asia
4
SE Asia Deal Review: VC funding rebounds in Apr, buoyed by one megadeal
5
Asia IPO market braces for headwinds from Trump's trade tempest
More Stories
Vietnam’s MoMo posts first full-year profit in 2024 amid strategy shift
Tiki’s plunge from soonicorn to sub-$10m valuation stuns investors, highlights harsh reset
Beyond the Buyout: India’s investment outlook faces a geopolitical test
GVMC covers 681.96 sq km in Visakhapatnam and Anakapalli districts.
DCDC plans to roll out 150 new clinics across the country in the coming months.
Everhope Oncology plans to scale to 10 cities in three years starting with Mumbai and Delhi.
The Sanghvi Family has also increased its stake in the company.
KKR will acquire up to 54% of equity in HCG from CVC Asia V.
The company has raised $4.25m in seed funding with participation from existing investor W Health Ventures.
The funding will help Raaz significantly expand its footprint.
The firm said it is on track to achieve its $500 million target by 2025.
The investment was from Strategic Situations Fund II.
